Daily pill doubles survival time for pancreatic cancer patients

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.

Več na: https://www.bbc.com/news/articles/cy82l435171o?at_medium=RSS&at_campaign=rss

nazaj